- Home
- PEB vs ATAI Comparison
PEB vs ATAI Comparison
Compare PEB & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PEB | ATAI |
|---|---|---|
| Founded | 2009 | 2018 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PEB | ATAI |
|---|---|---|
| Price | $11.48 | $4.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | $12.28 | ★ $14.33 |
| AVG Volume (30 Days) | 1.9M | ★ 3.2M |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,464,126,000.00 | $3,018,000.00 |
| Revenue This Year | $2.18 | $943.18 |
| Revenue Next Year | $0.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.99 | ★ 811.78 |
| 52 Week Low | $7.42 | $1.15 |
| 52 Week High | $14.21 | $6.75 |
Technical Indicators
Market Signals| Indicator | PEB | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 56.27 | 43.62 |
| Support Level | $11.30 | $3.88 |
| Resistance Level | $11.59 | $4.72 |
| Average True Range (ATR) | 0.31 | 0.24 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 77.27 | 16.07 |
Price Performance
Historical ComparisonAbout PEB Pebblebrook Hotel Trust of Beneficial Interest
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.